Patents by Inventor Claus Bollschweiler

Claus Bollschweiler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Coating Surfaces with Hydrophobins
    Publication number: 20080319168
    Abstract: A method for coating surfaces with hydrophobin fusions at a pH of ?4, and a surface having a coating which comprises at least one hydrophobin fusion.
    Type: Application
    Filed: February 7, 2006
    Publication date: December 25, 2008
    Applicant: BASF Aktiengesellschaft
    Inventors: Thomas Subkowski, Marvin Karos, Claus Bollschweiler, Ulf Baus, Patrick Rüdiger, Michael Lang, Thorsten Montag, Alexandra Kasprzyk
  • Keratin-Binding Polypeptides
    Publication number: 20080075684
    Abstract: The invention relates to novel keratin-binding protein active substances, and also to the production and use thereof. Particularly suitable keratin-binding polypeptides are sequences which are contained in human desmoplakin or are derived therefrom by altering the human desmoplakin polypeptide sequences such as amino acid insertions, substitutions or deletions. The polypeptide sequences of the human desmoplakin is represented in SEQ ID NO: 1. A suitable keratin-binding domain (domain B) is the polypeptide sequence SEQ ID NO: 1, position 2193 2481, in addition to functional equivalents thereof. An additional keratin-binding domain (domain C) is the polypeptide sequence SEQ ID NO: 1, position 2606 2871 and the functional equivalents thereof.
    Type: Application
    Filed: May 24, 2005
    Publication date: March 27, 2008
    Applicant: BASF Aktiengesellschaft
    Inventors: Heiko Barg, Thomas Subkowski, Hans-Georg Lemaire, Claus Bollschweiler, Arne Ptock
  • Thrombin muteins as antidotes for thrombin inhibitors
    Patent number: 6060300
    Abstract: The invention concerns thrombin muteins which have the following differences in their sequences as compared with natural thrombin: (a) the exchange of a Gly after Ala, the Gly being in the sequence environment Tyr-Gly-Phe and having position 558 in natural human thrombin (SEQ ID No. 14); (b) at least one exchange or deletion of the following radicals: (b1) His, located in the sequence environment Ala-His-Cys and having position 363 in natural human thrombin (SEQ ID No. 14); (b2) Asp, located in the sequence environment Arg-Asp-Ile and having position 419 in natural human thrombin (SEQ ID No. 14); (b3) Ser, located in the sequence environment Asp-Ser-Gly and having position 525 in natural human thrombin (SEQ ID No. 14). The invention further concerns the use of these muteins as antidotes.
    Type: Grant
    Filed: August 4, 1998
    Date of Patent: May 9, 2000
    Assignee: BASF Aktiengesellschaft
    Inventors: Martin Raditsch, Thomas Friedrich, Claus Bollschweiler, Martin Schmidt, Hans Wolfgang Hoffken, Jurgen Schweden, Klaus Rubsamen
  • Use of carboxylic acid derivatives as drugs
    Patent number: 5840722
    Abstract: A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I ##STR1##
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: November 24, 1998
    Assignee: BASF Aktiengesellschaft
    Inventors: Ernst Baumann, Uwe Josef Vogelbacher, Joachim Rheinheimer, Dagmar Klinge, Hartmut Riechers, Burkhard Kroger, Siegfried Bialojan, Claus Bollschweiler, Wolfgang Wernet, Liliane Unger, Manfred Raschack
  • Thrombin-inhibitory protein from ticks
    Patent number: 5827731
    Abstract: A novel thrombin-inhibitory protein from ticks with a molecular weight of about 8000 Dalton and the N terminus Leu-Asn-Val-Leu-Cys-Asn-Asn-Pro-His-Thr-Ala-Asp-Cys-Asn-Asn-Asp-Ala-Gln-Va l-Asp is described. The protein is suitable for controlling diseases.
    Type: Grant
    Filed: May 20, 1997
    Date of Patent: October 27, 1998
    Assignee: BASF Aktiengesellschaft
    Inventors: Thomas Friedrich, Siegfried Bialojan, Claus Bollschweiler, Christoph Kuenast
  • Recombinant production of proteins in yeast
    Patent number: 5741674
    Abstract: A process for the recombinant production of proteins in the yeast Hansenula comprises transforming Hansenula with an expression cassette which comprises the following structural elements encoded:L-A-P-GENwhereL is a leader sequence,A is an adaptor producing an alpha-helix structure,P is a processing signal andGEN is a structural gene for the required protein.
    Type: Grant
    Filed: March 1, 1996
    Date of Patent: April 21, 1998
    Assignee: Rhein Biotech Gesellschaft fur neue biotechnologische Prozesse und Produkte, mbH
    Inventors: Jurgen Schweden, Claus Bollschweiler, Michael Piontek, Ulrike Weydemann, Zbigniew A. Janowicz, Alexander W.M. Strasser
  • Recombinant production of proteins in yeast
    Patent number: 5672487
    Abstract: A process for the recombinant production of proteins in yeast comprises transforming the yeast with an expression cassette which comprises the following structural elements encoded:L-A-P-GENwhereL is a leader sequence of an animal peptide neurohormone,A is an adaptor producing an alpha-helix structure,P is a processing signal andGEN is a structural gene for the required protein.
    Type: Grant
    Filed: March 29, 1996
    Date of Patent: September 30, 1997
    Assignees: BASF Aktiengesellschaft, Rhein Biotech Gesellschaft
    Inventors: Jurgen Schweden, Claus Bollschweiler, Michael Piontek, Ulrike Weydemann, Gerd Gellissen